Mayo Clinic offers at-home colon cancer test

by Paul Walsh, Star Tribune (Minneapolis)

Mayo Clinic is taking another step toward making detection of colorectal cancer as convenient as possible, announcing Monday an at-home kit that arrives and is sent back in the mail, stool sample included.

In a joint announcement with Cologuard kit maker Exact Sciences of Madison, Wis., Mayo said the screening test will be available through its primary care doctors by prescription only.

Patients learn of their results in as little as two weeks from their doctor. A positive result prompts the need for a colonoscopy.

"Cologuard represents a significant advancement in identifying at its most treatable stage," Dr. Vijay Shah, chairman of gastroenterology and hepatology for Mayo, said in a statement accompanying the announcement. "We believe offering this new tool will promote patient and community public health and may move more patients to get screened earlier - a critical step in beating this prevalent and preventable cancer."

Cologuard was developed jointly by Mayo and Exact Sciences as the first - and so far, the only - noninvasive stool DNA screening test for colorectal cancer that has approval from the Food and Drug Administration.

The tests are meant for people 50 and older who are at average risk for colorectal cancer. Exact Science said it is the first noninvasive screening that analyzes both stool-based DNA and blood biomarkers to detect cancer and precancer.

With proper , colorectal cancer is highly preventable. However, 23 million Americans ages 50 to 75 are not getting screened as recommended, a factor in colorectal cancer remaining the second-leading cancer killer in the United States. Early detection can mean a five-year survival rate of more than 90 percent.

Dr. David Ahlquist, a Mayo gastroenterologist and co-inventor of the test, said, "I am hopeful that the test's efficacy and convenience will result in improved detection and survival rates for colorectal ."

4.5 /5 (4 votes)
add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Gene test aids cancer profile

3 hours ago

The first round of chemotherapy did little to suppress Ron Bose's leukemia. The second round, with 10 times the dose, knocked the proliferating blast cells down, but only by half.

How a common antacid could lead to cheaper anti-cancer drugs

20 hours ago

A popular indigestion medication can increase survival in colorectal cancer, according to research published in ecancermedicalscience. But in fact, scientists have studied this for years - and a group of cancer advocates want t ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.